Gudrun Windbichler

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 604 citations · Full text

Medicine, Biostatistics, Oncology +15

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

Gudrun Windbichler, H. Hausmaninger, W. Stummvoll et al. · British Journal of Cancer · 2000 · 245 citations · Full text

Medicine, Oncology, Surgery +8

Leiomyosarcoma of the Uterus: A Clinicopathologic Multicenter Study of 71 Cases

Klaus Mayerhofer, Andreas Obermair, Gudrun Windbichler et al. · Gynecologic Oncology · 1999 · 177 citations

Medicine, Oncology, Pathology +12

Prognostic Parameters in Endometrial Stromal Sarcoma: A Clinicopathologic Study in 31 Patients

Klaus Bodner, Barbara Bodner‐Adler, Andreas Obermair et al. · Gynecologic Oncology · 2001 · 126 citations

Medicine, Gynecology, Oncology +9

<i>HOXA11</i> DNA methylation—A novel prognostic biomarker in ovarian cancer

Heidi Fiegl, Gudrun Windbichler, Elisabeth Mueller‐Holzner et al. · International Journal of Cancer · 2008 · 102 citations

Medicine, Molecular Biology, Oncology +17